Breaking the species barrier for hepatitis delta virus
Benjamin Y. Winer, Alexander Ploss – 20 August 2015
Benjamin Y. Winer, Alexander Ploss – 20 August 2015
Jens Bohnekamp, Thomas M. Magin – 18 August 2015
Lung‐Yi Lee, Calvin Harberg, Kristina A. Matkowskyj, Shelly Cook, Drew Roenneburg, Sabine Werner, Jeffrey Johnson, David P. Foley – 18 August 2015 – Hepatic ischemia/reperfusion injury (IRI) is a critical component of hepatic surgery. Oxidative stress has long been implicated as a key player in IRI. In this study, we examine the cell‐specific role of the nuclear factor (erythroid‐derived 2)–like 2 (Nrf2)–antioxidant response element pathway in warm hepatic IRI.
Joel T. Haas, Bart Staels – 17 August 2015
Ahmed Hassaan Qavi, Sahla Hammad, Atif I. Rana, Mohammad Salih, Najmul Hassan Shah, Faisal S. Dar, Arsalan Ahmad – 17 August 2015
Ibtesam Hilmi – 17 August 2015
Zobair M. Younossi, Munkhzul Otgonsuren, Linda Henry, Chapy Venkatesan, Alita Mishra, Madeline Erario, Sharon Hunt – 14 August 2015 – Hepatocellular carcinoma (HCC) is increasingly reported in patients with nonalcoholic fatty liver disease (NAFLD). Our aim was to assess the prevalence and mortality of patients with NAFLD‐HCC.
Zobair M. Younossi, Munkhzul Otgonsuren, Linda Henry, Chapy Venkatesan, Alita Mishra, Madeline Erario, Sharon Hunt – 14 August 2015 – Hepatocellular carcinoma (HCC) is increasingly reported in patients with nonalcoholic fatty liver disease (NAFLD). Our aim was to assess the prevalence and mortality of patients with NAFLD‐HCC.
Julio A. Gutierrez, Andres Carrion, Kalyan Ram Bhamidimarri, Adam L. Peyton – 13 August 2015
Martin Wagner, Sungwoo Choi, Katrin Panzitt, Jennifer L. Mamrosh, Jae Man Lee, Alex Zaufel, Rui Xiao, Ruth Wooton‐Kee, Marcus Ståhlman, Christopher B. Newgard, Jan Borén, David D. Moore – 12 August 2015 – Balance of labile methyl groups (choline, methionine, betaine, and folate) is important for normal liver function. Quantitatively, a significant use of labile methyl groups is in the production of phosphatidylcholines (PCs), which are ligands for the nuclear liver receptor homolog‐1 (LRH‐1).